We have experienced a Takayasu arteritis (TA) 
Introduction

Takayasu arteritis (TA) is an idiopathic systemic granulomatous vasculitis of the large and medium-sized vessels, and tumor necrosis factor (TNF) is important in the formation of granuloma (1). The efficacy of TNF blockers has been described in TA that was not controlled by glucocorticoid therapy or other immunosuppressants in the USA
F i g u r e 1 . Ar t e r i a l wa l l t h i c k e n i n g ( a s c e n d i n g a o r t a , a o r t i c a r c h a n d p u l mo n a r y a r t e r y h i g hl i g h t e d b y a r r o wh e a d s ) d e t e r mi n e d b y MRI . (1, (3) (4) (5) . Glucocorticoid therapy is usually introduced for TA, but glucocorticoid alone is sometimes not efficient; Kerr et al reported that about half of active TA patients did not respond well to glucocorticoid alone (6) . In addition to glucocorticoid, an immunosuppressive regime such as cyclophosphomide, methotrexate and azathioprine has been used to treat TA (6) (7) (8) 
F i g u r e 2 . Di l a t a t i o n o f b o t h t h e a s c e n d i n g a o r t a a n d t h e d e s c e n d i n g a o r t a d e t e r mi n e d b y MRA. T h e a r r o wh e a d i n d i c a t e s t h e p o r t i o n .
(data not shown
Discussion
The pathogenesis of TA includes vessel injury due to products from activated T cells, natural killer cells, γ/δ T cells and macrophages (1). One of the important humoral factors is TNF-α, the molecular target for human autoimmune diseases
